Romania Lumasiran Market (2025-2031) | Size & Revenue, Outlook, Companies, Competitive Landscape, Segmentation, Growth, Trends, Share, Industry, Forecast, Analysis, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Romania Country Macro Economic Indicators

3.2 Romania Lumasiran Market Revenues & Volume, 2021 & 2031F

3.3 Romania Lumasiran Market - Industry Life Cycle

3.4 Romania Lumasiran Market - Porter's Five Forces

3.5 Romania Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Romania Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Romania Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F

3.8 Romania Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 Romania Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 Romania Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of rare diseases, such as Primary Hyperoxaluria type 1 (PH1), which can be treated with Lumasiran.

4.2.2 Growing awareness and adoption of advanced therapies for genetic disorders in the healthcare sector.

4.2.3 Favorable government initiatives and policies supporting the development and access to innovative treatments like Lumasiran.

4.3 Market Restraints

4.3.1 High cost associated with Lumasiran treatment may limit accessibility for a significant portion of the population.

4.3.2 Stringent regulatory requirements and approval processes for new drugs could delay market entry and adoption.

4.3.3 Limited healthcare infrastructure and resources in certain regions of Romania may impact the distribution and administration of Lumasiran.

6.1 Romania Lumasiran Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Romania Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Romania Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F

6.1.4 Romania Lumasiran Market Revenues & Volume, By others, 2021- 2031F

6.2 Romania Lumasiran Market, By Application

6.2.1 Overview and Analysis

6.2.2 Romania Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F

6.2.3 Romania Lumasiran Market Revenues & Volume, By Others, 2021- 2031F

6.3 Romania Lumasiran Market, By Dosage form

6.3.1 Overview and Analysis

6.3.2 Romania Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F

6.3.3 Romania Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F

6.4 Romania Lumasiran Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 Romania Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.4.3 Romania Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F

6.4.4 Romania Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F

6.4.5 Romania Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F

6.5 Romania Lumasiran Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 Romania Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F

6.5.3 Romania Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.4 Romania Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F

6.6 Romania Lumasiran Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 Romania Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 Romania Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.6.4 Romania Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7.1 Romania Lumasiran Market Export to Major Countries

7.2 Romania Lumasiran Market Imports from Major Countries

8.1 Number of patients diagnosed with PH1 or other rare genetic disorders receiving Lumasiran treatment.

8.2 Rate of physician and patient education programs on Lumasiran therapy.

8.3 Percentage increase in reimbursement coverage for Lumasiran by healthcare payers.

8.4 Adoption rate of Lumasiran compared to traditional treatment options.

8.5 Number of clinical trials and research studies on the effectiveness and safety of Lumasiran in Romania.

9.1 Romania Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Romania Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Romania Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F

9.4 Romania Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 Romania Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 Romania Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Romania Lumasiran Market Revenue Share, By Companies, 2024

10.2 Romania Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters